Novavax (United States)

Novavax (United States)

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novavax (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

82%


Total
Publications

312


Total Open
Publications

257


Total
Citations

13K


Open Access
Percentage

82%


Total
Publications

312


Total Open
Publications

257


Total
Citations

13K

Wikipedia

Website

download

Breakdown

18% 39% 25% 18%

Publisher Open

18%

Both

39%

Other Platform Open

25%

Closed

18%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

43%OA Journal

OA Journal 43%

77

Hybrid 44%

79

No Guarantees 13%

23

Other Platform Open

Domain 71%

142

Other Internet 29%

57

Preprint 25%

50

Institution 21%

42

Public 8%

16

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
146
Europe PMC
Domain
51
DOI
Other Internet
51
medRxiv
Preprint
29
University of Oxford - Oxford University Research Archive (ORA)
Institution
12
Semantic Scholar
Public
12
St George's University of London - St George's Online Research Archive
Institution
11
bioRxiv
Preprint
10
Research Square
Preprint
9
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
6
1 / 5

Data updated 7 April 2025

Share

Share

Share